The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTFB.L Regulatory News (MTFB)

  • There is currently no data for MTFB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Posters presented at IDWeek New Orleans

15 Sep 2016 07:00

RNS Number : 8824J
Motif Bio PLC
15 September 2016
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

 

.Motif Bio plc

("Motif Bio" or the "Company")

 

15 September 2016

POSTER PRESENTATION AT IDWEEK

 

Motif Bio plc (AIM: MTFB), the clinical stage biopharmaceutical company specialising in developing novel antibiotics, announces that it will be presenting two poster studies at IDWeek, October 26 to 30 in New Orleans, USA.

 

IDWeek is an annual gathering of 6,000 practitioners who are members of the Infectious Disease Society of America (IDSA), the Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA) and the Pediatric Infectious Diseases Society (PIDS) and represents the largest gathering of practicing professionals dedicated to the treatment, control and eradication of infectious diseases.

 

Motif Bio will be presenting two posters at the session titled 'Antimicrobial Pharmacokinetics and Pharmacodynamics' on Saturday, October 29, 2016 between 12.30 and 2.00 pm.

 

The first poster is titled 'The Use of PK/PD Systems Analyses to Determine the Optimal Fixed Dosing Regimen of Iclaprim (ICL) for a Phase III ABSSSI Clinical Trial'.

 

The second poster is titled 'A 2012-2014 Global Antimicrobial Surveillance of Iclaprim Against Clinical Strains Causing Hospital-Associated Bacterial Pneumonia (HABP) and Skin and Skin Structure Infections (SSSI)'.

 

Following the conclusion of the conference, both poster presentations will be made available on the Company website: www.motifbio.com

 

For further information please contact:

 

Motif Bio plc

Richard Morgan (Chairman)

Graham Lumsden (Chief Executive Officer)

 

info@motifbio.com

 

Walbrook PR Ltd. (FINANCIAL PR & IR)

Paul McManus

Mike Wort

+44 (0)20 7933 8780 or motifbio@walbrookpr.com

Mob: +44 (0)7980 541 893

Mob: +44 (0)7900 608 002

 

 

MC Services AG (EUROPEAN IR)

 

Raimund Gabriel

+49 (0)89 210 2280

 

About Motif Bio

Motif Bio is a clinical-stage biopharmaceutical company, engaged in the research and development of novel antibiotics designed to be effective against serious and life-threatening infections in hospitalized patients caused by multi-drug resistant bacteria. Our lead product candidate, iclaprim, is being developed for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and hospital acquired bacterial pneumonia (HABP), including ventilator associated bacterial pneumonia (VABP), which is often caused by MRSA (methicillin resistant Staphylococcus aureus). We are currently enrolling and dosing patients in two global Phase 3 clinical trials with an intravenous formulation of iclaprim, for the treatment of ABSSSI, which are expected to be completed in 2017.

 

The ID Week partners:

 

The Infectious Diseases Society of America (IDSA) represents physicians, scientists and other health care professionals who specialize in infectious diseases. IDSA's purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases. www.idsociety.org

The Society for Healthcare Epidemiology of America (SHEA) is a professional society representing physicians and other healthcare professionals around the world with expertise in healthcare epidemiology and infection prevention and control. SHEA's mission is to prevent and control healthcare-associated infections and advance the field of healthcare epidemiology. www.shea-online.org

The HIV Medicine Association (HIVMA) promotes quality in HIV care by advocating policies and supporting programs that ensure a comprehensive and humane response to the AIDS pandemic informed by science and social justice. HIVMA represents the diversity of medical subspecialties practicing HIV medicine-including internal medicine, family practice, infectious diseases, oncology, and obstetrics-gynecology. www.hivma.org

The Pediatric Infectious Diseases Society (PIDS) represents professionals dedicated to the treatment, control and eradication of infectious diseases affecting children. Membership includes physicians and doctoral-level scientists who are involved in clinical practice, research, teaching and/or administration. www.pids.org

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAAKQDDCBKDCCD
Date   Source Headline
7th Mar 201912:07 pmRNSSecond Price Monitoring Extn
7th Mar 201912:02 pmRNSPrice Monitoring Extension
19th Feb 20197:00 amRNSConference Call and Webcast
18th Feb 20197:00 amRNSAmendment Agreement with Hercules Capital
15th Feb 20194:28 pmRNSHolding(s) in Company
15th Feb 20194:26 pmRNSHolding(s) in Company
14th Feb 20197:00 amRNSComplete Response Letter from the FDA
5th Feb 20197:00 amRNSExercise of Warrants
23rd Jan 20194:31 pmRNSExercise of Warrants
1st Nov 20184:40 pmRNSSecond Price Monitoring Extn
1st Nov 20184:35 pmRNSPrice Monitoring Extension
31st Oct 20187:00 amRNSJefferies London Healthcare Conference
30th Oct 20184:35 pmRNSPrice Monitoring Extension
16th Oct 20184:40 pmRNSSecond Price Monitoring Extn
16th Oct 20184:35 pmRNSPrice Monitoring Extension
3rd Oct 20188:01 amRNSMotif Bio Presents New Iclaprim Data at IDWeek
28th Sep 20187:01 amRNSMotif Bio Notes Statement from Amphion Innovations
25th Sep 20187:00 amRNSHalf-year Report
20th Sep 20187:00 amRNSUpcoming Scientific Conferences
5th Sep 20187:00 amRNSIclaprim Data presented at ESCMID/ASM Conference
29th Aug 20184:35 pmRNSPrice Monitoring Extension
21st Aug 20187:15 amRNSMotif Bio notes statement from Amphion Innovations
17th Aug 20187:00 amRNSIclaprim Data at ESCMID/ASM Conference
14th Aug 20184:49 pmRNSHolding(s) in Company
14th Aug 20184:48 pmRNSHolding(s) in Company
14th Aug 20187:00 amRNSFDA Acceptance of New Drug Application
9th Aug 20187:00 amRNSInvestor Events in August and September
8th Aug 20187:00 amRNSNotice of Allowance for Two U.S. Iclaprim Patents
2nd Aug 20184:35 pmRNSPrice Monitoring Extension
3rd Jul 20184:48 pmRNSHolding(s) in Company
3rd Jul 20187:00 amRNSDirectorate Change
26th Jun 201811:57 amRNSExercise of Stock Options
19th Jun 20181:58 pmRNSResult of AGM
14th Jun 20187:00 amRNSMotif Bio Submits NDA for Iclaprim
11th Jun 201811:41 amRNSHolding(s) in Company
11th Jun 20187:00 amRNSMotif Bio present New Iclaprim Data at ASM Microbe
8th Jun 20185:08 pmRNSHolding(s) in Company
31st May 20187:00 amRNSJefferies Global Healthcare Conference
25th May 20184:04 pmRNSHolding(s) in Company
24th May 20184:39 pmRNSHolding(s) in Company
23rd May 20185:42 pmRNSHolding(s) in Company
23rd May 20187:00 amRNSMotif Bio notes statement from Amphion Innovations
17th May 20182:24 pmRNSResult of Placing
17th May 20189:55 amRNSProposed Placing to raise approximately £10m
9th May 20187:00 amRNSAppointment of Vice President,Clinical Development
8th May 20187:00 amRNSMotif Bio to Present Iclaprim Data at ASM Microbe
1st May 20187:00 amRNSREVIVE-2 Study Results Published in Journal
19th Apr 20187:00 amRNSNew Iclaprim Data being Presented at ECCMID 2018
17th Apr 20184:40 pmRNSSecond Price Monitoring Extn
17th Apr 20184:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.